"A snafu at a Baltimore manufacturing plant ruined about 15 million doses of Johnson & Johnson’s 1-shot COVID-19 vaccine, delaying future shipments of the vaccine in the United States."

“Late on Friday afternoon, when an FDA panel unanimously endorsed the J&J Covid vaccine finding that its benefits outweigh any risks, we wrote that the "FDA could now give the green light to the single-dose vaccine as early as Saturday, and it probably will." And just after 6 pm on Saturday, that's precisely what happened when the Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-shot, non-mRNA Covid-19 vaccine for emergency use for people 18 and older beginning the rollout of millions of doses of a third effective vaccine that could reach Americans by early next week.”

“While it was so widely expected the announcement was merely a formality, just after 5pm on Friday the FDA Advisory Panel voted unanimously (22-0) to endorse the (one-shot, no mRNA) J&J vaccine, saying the benefits outweigh the risks, and recommended the agency grant emergency authorization, moving the nation's third vaccine one step closer to getting into Americans' arms.”

The is the advisory committee of the FDA.  FDA approval could come as early as tomorrow.

The Johnson and Johnson Advisory Committee (adcom) meets and possibly votes on Friday.  The New York Times suspicion is that it could be approved as early as Saturday.